Patents for C12Q 1 - Measuring or testing processes involving enzymes or micro-organisms; Compositions therefor; Processes of preparing such compositions (300,231)
12/2006
12/14/2006US20060281140 Coagulation tests at ambient temperature
12/14/2006US20060281138 Methods for diagnosis of low grade astrocytoma
12/14/2006US20060281129 Method for detecting biopolymers
12/14/2006US20060281128 Compositions and methods using lentivirus-based vectors for generating immune responses
12/14/2006US20060281127 Promoter sequences for urocortin II and the use thereof
12/14/2006US20060281126 Methods for monitoring the expression of alternatively spliced genes
12/14/2006US20060281125 ICBP90 polypeptide and its fragments and polynucleotides coding for said polypeptides and applications for diagnosing and treating cancer
12/14/2006US20060281124 Device and method for purification of biological materials
12/14/2006US20060281123 Polynucleotide comprising single-nucleotide polymorphism associated with colorectal cancer, microarray and diagnostic kit comprising the same, and method of diagnosing colorectal cancer using the same
12/14/2006US20060281122 Methods for the identification, assessment, and treatment of patients with cancer therapy
12/14/2006US20060281121 Computing with biomolecules
12/14/2006US20060281120 determining risk of developing ARM in a human subject by detecting the presence of a thymine or guanine at base 270 SEQ ID NO 20 (rs10490924) from a sample
12/14/2006US20060281119 Controlled alignment of nano-barcodes encoding specific information for scanning probe microscopy (SPM)
12/14/2006US20060281118 efficiently purifying proteasomes using fusion proteins having homology to ubiquitin; immobilizing ubiquitin amino acid sequence to solid support, incubate with cell lysate, elute proteasome from solid support
12/14/2006US20060281117 Alternatively spliced isoform of calcium channel, voltage dependent, alpha-1G subunit (CACNA1G)
12/14/2006US20060281116 In situ heat induced antigen recovery and staining apparatus and method
12/14/2006US20060281115 MAX quadruplex nucleic acids and uses thereof
12/14/2006US20060281114 Methods and compositions for assessment of pulmonary function and disorders
12/14/2006US20060281113 Accessible polynucleotide libraries and methods of use thereof
12/14/2006US20060281112 Design of capture molecules for the detection of amplicons with high sensitivity
12/14/2006US20060281111 isolated polyclonal antibody of given sequence; use in detecting, diagnosing, staging or monitoring progression of cancer, inflammatory, autoimmune, cardiovascular, and neurological disorders
12/14/2006US20060281110 Methods to identify antimicrobial compounds that interrupt ribosome biogenesis
12/14/2006US20060281109 Polymerases
12/14/2006US20060281108 Compositions and methods for the analysis of degraded nucleic acids
12/14/2006US20060281107 consists of between 2 and 60 different probe sets wherein at least 20% of the different probe sets comprise one or more isolated polynucleotides that selectively hybridize to a genomic region
12/14/2006US20060281106 Using polymerase regulatory sequences as evaluative tool in identifying modulators for treatment of cell proliferative disorders
12/14/2006US20060281105 High throughput multiplex DNA sequence amplifications
12/14/2006US20060281104 Leuco dye particles and uses thereof
12/14/2006US20060281103 Increased sensitivity of nucleic acid-based detection of organisms by fractionation of target genomes
12/14/2006US20060281102 Methods for detecting genetic haplotypes by interaction with probes
12/14/2006US20060281101 Biobriefcase
12/14/2006US20060281100 Thiotriphosphate nucleotide dye terminators
12/14/2006US20060281099 Q-melt for polymorphism detection
12/14/2006US20060281098 Method and kits for multiplex hybridization assays
12/14/2006US20060281096 Methods and kits for detecting genetically modified organism (GMO)
12/14/2006US20060281095 44 human secreted proteins
12/14/2006US20060281094 Apparatus for processing a fluid sample
12/14/2006US20060281093 Erbb receptor methods and kits for monitoring chemotherapy resistance
12/14/2006US20060281092 Method for the reverse transcription and/or amplification of nucleic acids
12/14/2006US20060281091 Genes regulated in ovarian cancer a s prognostic and therapeutic targets
12/14/2006US20060281090 Capsid-modified adenovirus vectors and methods of using the same
12/14/2006US20060281089 Detecting presence of mutant bcl gene of given sequence; identifying patients resistant to chemotherapy or radiation treatments
12/14/2006US20060281088 Markers for lxr activation
12/14/2006US20060281087 Titanium dioxide complex having molecule distinguishability
12/14/2006US20060281086 Comprising reverse transcription (RT) of mRNA; polymerase chain reaction; highly sensitive ; can be partially or fully automated
12/14/2006US20060281085 Diagnostics and therapeutics for diseases associated with phosphodiesterase 1b (pde1b)
12/14/2006US20060281084 Method of detecting bifidobacterium infantis
12/14/2006US20060281083 Identification of genes involved in angiogenesis, and development of an angiogenesis diagnostic chip to identify patients with impaired angiogenesis
12/14/2006US20060281081 Method of diagnosing colon and gastric cancers
12/14/2006US20060281080 Novel lipases and uses thereof
12/14/2006US20060281079 Preparing a cDNA molecule by contacting an RNA molecule, in the presence of dNTPs, with a non-LTR retrotransposon protein or polypeptide having reverse transcriptase, producing a cDNA molecule complementary to the RNA molecule
12/14/2006US20060281078 Human fast-1 gene
12/14/2006US20060281077 Spectrophotometric evaluation of bodily fluid; genome analysis and diagnostics; detecting binding or cleavage of one or more specific binding substances to the colorimetric resonant reflectance optical biosensor surface, or to their respective binding partners which are immobilized
12/14/2006US20060281076 Substrate functionalization method for high sensitivity applications
12/14/2006US20060281075 Purification of viruses, proteins and nucleic acids
12/14/2006US20060281074 Affinity-based detection of biological targets
12/14/2006US20060281071 Stearoyl-CoA desaturase assay
12/14/2006US20060281070 Synthetic genetic expression cassette comprising human preproenkephalin sequences for use in treating neuropathic pain
12/14/2006US20060281069 Classifying activity of membrane protein modulators; obtain cells, expose to modulators, pulse cells with electricity, detecting fluorescence emission from cells
12/14/2006US20060281068 Cytological methods for detecting a disease condition such as malignancy by Raman spectroscopic imaging
12/14/2006US20060281067 Monolithic biosensors containing a modified bioluminescent microorganism; Optical Application Specific Integrated Circuit
12/14/2006US20060280758 Modified vaccinia ankara virus variant
12/14/2006US20060280754 Especially arenaviruses, coronaviruses, filoviruses, orthomyxoviruses, paramyxoviruses, and retroviruses
12/14/2006US20060280751 Method for enhancing efficacy of preparation of monoclonal antibody
12/14/2006US20060280739 Novel human beta-2 integrin alpha subunit
12/14/2006US20060280723 Interferon for treating or preventing a coronaviral infection
12/14/2006US20060280684 Using lymphocyte gene expression profiles as diagnostic indicator of asthma, allergic and autoimmune disorders
12/14/2006US20060280649 Temperature/irradiation/polymerization indicators
12/14/2006US20060278538 Methods and devices for controlling the impact of short circuit faults on co-planar electrochemical sensors
12/14/2006US20060278537 Disposable oxygen sensor and method for correcting oxygen effect on oxidase-based analytical devices
12/14/2006DE10361927B4 Ionenkanal-Sensorarray Ion-channel sensor array
12/14/2006DE102005027111A1 Test system to analyze expression of mycotoxin biosynthetic genes in situ, comprises deoxyribonucleic acid chip on which oligonucleotides are applied and are homologous to mycotoxin biosynthetic genes of mushroom species and fusaria
12/14/2006DE102005026710A1 Verfahren zum Testen von Substanzen oder Substanzgemischen, dessen Verwendung und entsprechende Analysekits A method for testing substances or mixtures of substances whose use and corresponding analytical kits
12/14/2006DE102005025191A1 Verfahren zum Identifizieren von fungizid wirksamen Verbindungen basierend auf Isopentenylpyrophosphat-Isomerasen A method for identifying fungicidally active compounds based on isopentenyl pyrophosphate isomerases
12/14/2006DE10111457B4 Diagnoseeinrichtung Diagnostic device
12/14/2006CA2725709A1 Susceptibility genes for age-related maculopathy (arm) on chromosome 10q26
12/14/2006CA2650841A1 Method of profiling a cell population
12/14/2006CA2611728A1 Methods for the identification, assessment, and treatment of patients with cancer therapy
12/14/2006CA2611696A1 Use of gene expression profiling to predict survival in cancer patient
12/14/2006CA2611446A1 Npy y2 agonist for use as therapeutic agent for disease accompanied by diarrhea
12/14/2006CA2611445A1 Method for evaluation of compound using rsk1
12/14/2006CA2611409A1 Novel nucleotide and amino acid sequences, and assays and methods of use thereof for diagnosis
12/14/2006CA2611091A1 Biosensor strips and methods of preparing same
12/14/2006CA2611011A1 Treatment of cns disorders associated with mutations in genes encoding lysosomal enzymes
12/14/2006CA2610960A1 Expression profiles of peripheral blood mononuclear cells for inflammatory bowel diseases
12/14/2006CA2610863A1 Methods for detection and typing of nucleic acids
12/14/2006CA2610752A1 Identification of tumors and tissues
12/14/2006CA2610268A1 Methods and composition for diagnosis of neurological disorders in body fluids
12/14/2006CA2609206A1 Compositions, methods and kits for determining the presence of chlamydophila pneumoniae in a test sample
12/14/2006CA2606293A1 Hdac regulation assays, compounds and therapeutic compositions
12/14/2006CA2604676A1 Diagnostic histopathology using multiplex gene expression fish
12/14/2006CA2595923A1 Methods for identifying compounds that inhibit hiv infection
12/13/2006EP1732021A1 Method of searching specific base sequence
12/13/2006EP1731913A2 Methods and compositions for determining lipid peroxidation levels in oxidant stress syndromes and diseases
12/13/2006EP1731912A2 Peptide selection method
12/13/2006EP1731620A1 Method for the diagnosis of immune graft tolerance
12/13/2006EP1731619A2 Tumour markers
12/13/2006EP1731613A2 Nucleotide sequence for the zwf gene
12/13/2006EP1731611A2 Eimeria hydrophilic polypeptides as vaccines
12/13/2006EP1731610A1 Proteins imparting boron-tolerance and genes thereof